Oral Cancer

When you come to us for diagnosis or treatment for oral cancer, our multidisciplinary team of specialists works quickly to create a customized treatment plan that meets your needs. Our surgeons, periodontists, oncologists, and speech and swallowing therapists collaborate to provide comprehensive, compassionate care throughout treatment and recovery. Also, you may be eligible to participate in clinical trials, which offer new treatment approaches to oral cancer and oral precancerous growths.

Clinical Trials and Research Studies

Phase 1

An Open Label Phase 1 Dose-Escalation Study to Evaluate the Safety and Preliminary Antitumor Activity of TAK-676 with Pembrolizumab Following Radiation Therapy in the Treatment of Non-Small-Cell Lung Cancer Triple-Negative Breast Cancer or Squamous Cell Carcinoma of the Head and Neck that has Progressed on Checkpoint Inhibitors

Learn More

Phase 4

A phase 4 single-arm open-label clinical study of pembrolizumab (MK-3475) to evaluate the efficacy and safety of MK-3475 plus carboplatin and paclitaxel as first-line treatment of recurrent/ metastatic head and neck squamous cell carcinoma.

Learn More

Phase 5

Phase 1 and phase 2a first-in-human study of DRP-104 a glutamine antagonist in adult patients with advanced solid tumors

Learn More

Phase 1

A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study to Determine the Safety Tolerability Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination with ABBV-181 in Subjects with Locally Advanced or Metastatic Solid Tumors (AbbVie M19-345)

Learn More